AEROVATE THERAPEUTICS, INC.

Analyst Reco. Aerovate Therapeutics, Inc.

Equities

AVTE

US0080641071

Real-time Estimate Cboe BZX Other stock markets 10:16:17 2024-04-25 am EDT			5-day change	1st Jan Change
20.04 ^USD	-5.50%		-6.25%	-10.52%

Apr. 12	Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing	MT
Apr. 04	Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing	Apr. 12	MT
Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing	Apr. 04	MT
Aerovate Therapeutics Insider Sold Shares Worth $908,046, According to a Recent SEC Filing	Mar. 21	MT
Wedbush Adjusts Aerovate Therapeutics Price Target to $48 From $50, Maintains Outperform Rating	23-08-15	MT
Wedbush Lowers Aerovate Therapeutics' Price Target to $50 From $54, Keeps Outperform Rating	23-05-17	MT
Guggenheim Initiates Aerovate Therapeutics at Buy With $36 Price Target	23-03-01	MT
Wedbush Raises Aerovate Therapeutics' PT to $54 From $27 on Increased Confidence in Inhaled TKIs, AV-10; Keeps Outperform Rating	22-12-12	MT
BTIG Upgrades Aerovate Therapeutics to Buy From Neutral, Price Target Is $27	22-12-06	MT
Wedbush Analyst Assumes Coverage on Aerovate Therapeutics at Outperform With $27 Price Target, Down From $32	22-09-19	MT
Wedbush Analyst Assumes Coverage on Aerovate Therapeutics at $27, Down From $32; Outperform Rating Kept	22-09-19	MT
Wedbush Lifts Price Target on Aerovate Therapeutics to $32 From $23, Keeps Outperform Rating	22-08-17	MT
BTIG Downgrades Aerovate Therapeutics to Neutral From Buy	22-08-16	MT
BTIG Initiates Aerovate Therapeutics at Buy With $24 Price Target	22-02-11	MT
AEROVATE THERAPEUTICS : Evercore ISI Group Initiates Aerovate Therapeutics at Outperform Rating With $30 Price Target	21-07-26	MT
AEROVATE THERAPEUTICS : Jefferies Starts Aerovate Therapeutics at Buy With $21 Price Target	21-07-26	MT
AEROVATE THERAPEUTICS : Cowen Initiates Coverage on Aerovate Therapeutics With Outperform Rating	21-07-26	MT
AEROVATE THERAPEUTICS : Wedbush Starts Aerovate Therapeutics at Outperform With $23 Price Target	21-07-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer